Reports of side-effects from Bayer’s Xarelto grow -Spiegel

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

Xarelto is used to reduce the risk of stroke and blood clots in people with atrial fibrillation, not caused by a heart valve problem. There is limited information on how effective it is compared to warfarin (coumadin). The FDA approved it’s use in the US in November 2011.

A German magazine, Der Spiegel,  published an article about the extrordinary amount of reported side effects in Germany from the drug Xarelto. They state:

  • In 2013, for 8 months, 968 cases of (suspected) side effects, including 72 deaths.
  • In 2012, for the full year, 750 cases of side-effects, including 58 cases of death.

Bayer projects $2b in sales for Xarelto. Via Reuters

– MedShadow Staff


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement